The Photosensitising Clinical Agent Verteporfin Is an Inhibitor of SPAK and OSR1 Kinases.
Saved in:
| Title: | The Photosensitising Clinical Agent Verteporfin Is an Inhibitor of SPAK and OSR1 Kinases. |
|---|---|
| Authors: | AlAmri MA; School of Pharmacy, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Kadri H; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3NB, UK., Alderwick LJ; School of Biosciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Jeeves M; School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK., Mehellou Y; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3NB, UK. |
| Source: | Chembiochem : a European journal of chemical biology [Chembiochem] 2018 Oct 04; Vol. 19 (19), pp. 2072-2080. Date of Electronic Publication: 2018 Aug 22. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 100937360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-7633 (Electronic) Linking ISSN: 14394227 NLM ISO Abbreviation: Chembiochem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1439-7633 |
|---|---|
| DOI: | 10.1002/cbic.201800272 |
